SCHEMBL5517451

SCHEMBL5517451

COc1ccc(C(=O)/C=C/c2ccc(O)cc2)c(O)c1Cc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.67
MEN1 O00255 2/20 0.67
MAPT P10636 2/20 0.67
KMT2A Q03164 2/20 0.67
LMNA P02545 1/20 0.67
CAPN1 P07384 1/20 0.57
PARP1 P09874 1/20 0.57
MAOA P21397 1/20 0.57
MCL1 Q07820 1/20 0.56
CYP1A1 P04798 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP1B1 Q16678 1/20 0.55
XDH P47989 1/20 0.54
APP P05067 1/20 0.53
ABCG2 Q9UNQ0 3/20 0.52
PTPN1 P18031 1/20 0.51
DHODH Q02127 1/20 0.51
CTSL P07711 1/20 0.50
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5517453 1.00 MAOB (0.67) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL8977026 0.85 MAPT (0.53) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL8977029 0.85 MAPT (0.53) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL5519707 0.84 PTPN1 (0.62) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL5519708 0.84 PTPN1 (0.62) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL5513574 0.81 MAOB (1.00) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL1024850 0.81 MAOB (1.00) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL30745460 0.80 HDAC3 (0.53) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL5516595 0.80 MAOB (0.67) MAOBMEN1MAPTKMT2ALMNA
SCHEMBL5516596 0.80 MAOB (0.67) MAOBMEN1MAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US claimed
EP-1623704-A1 THERAPEUTIC AGENT TAKARA BIO INC. (JP) 2006-02-08 EP claimed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
US-20070092551-A1 Therapeutic agent TAKARA BIO INC. (JP) 2007-04-26 US disclosed
EP-1623704-A1 THERAPEUTIC AGENT TAKARA BIO INC. (JP) 2006-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070092551-A1 Therapeutic agent FABP4, GPR119, IAPP MAOB 4382/4885MEN1 2467/4885MAPT 2256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.